LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 232

Search options

  1. Article ; Online: Neurofilaments as Decay Rate Biomarker in Spinocerebellar Ataxia Type 1: Highlighting Key Questions of Application and Future Challenges.

    Nacmias, Benedetta

    Neurology

    2022  Volume 98, Issue 20, Page(s) 821–822

    MeSH term(s) Biomarkers ; Disease Progression ; Humans ; Intermediate Filaments ; Spinocerebellar Ataxias/diagnosis ; Spinocerebellar Ataxias/genetics
    Chemical Substances Biomarkers
    Language English
    Publishing date 2022-03-09
    Publishing country United States
    Document type Editorial ; Comment
    ZDB-ID 207147-2
    ISSN 1526-632X ; 0028-3878
    ISSN (online) 1526-632X
    ISSN 0028-3878
    DOI 10.1212/WNL.0000000000200360
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Does diet matter? The implications of dietary habits for dementia.

    Peters, Nils / Nacmias, Benedetta

    Neurology

    2022  

    Language English
    Publishing date 2022-10-12
    Publishing country United States
    Document type Editorial
    ZDB-ID 207147-2
    ISSN 1526-632X ; 0028-3878
    ISSN (online) 1526-632X
    ISSN 0028-3878
    DOI 10.1212/WNL.0000000000201420
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: The Association Between Positive Amyloid-PET and Cognitive Decline Is Not Always Supportive of Alzheimer's Disease: Suggestions from a Case Report.

    Lombardi, Gemma / Berti, Valentina / Ginestroni, Andrea / Nacmias, Benedetta / Sorbi, Sandro

    Journal of Alzheimer's disease reports

    2024  Volume 8, Issue 1, Page(s) 281–288

    Abstract: Amyloid-β deposition is the pathological hallmark of both cerebral amyloid angiopathy and Alzheimer's disease dementia, clinical conditions that can share cognitive decline and positive Amyloid-PET scan. A case is reported involving an 82-year-old ... ...

    Abstract Amyloid-β deposition is the pathological hallmark of both cerebral amyloid angiopathy and Alzheimer's disease dementia, clinical conditions that can share cognitive decline and positive Amyloid-PET scan. A case is reported involving an 82-year-old Italian female who presented initially a memory deficit, later transient focal neurologic episodes, and finally two symptomatic lobar intracerebral hemorrhages. In light of these events, MRI and PET imaging findings, acquired before cerebral hemorrhages, are reconsidered and discussed, highlighting the utility of Amyloid-PET in supporting an
    Language English
    Publishing date 2024-02-16
    Publishing country Netherlands
    Document type Case Reports
    ISSN 2542-4823
    ISSN (online) 2542-4823
    DOI 10.3233/ADR-230183
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Creutzfeldt-Jakob Disease in a Patient with Previous COVID-19 Infection: "The Virus Caused the Derangement in My Brain".

    Leccese, Deborah / Cornacchini, Sara / Nacmias, Benedetta / Sorbi, Sandro / Bessi, Valentina

    Journal of Alzheimer's disease reports

    2023  Volume 7, Issue 1, Page(s) 129–134

    Abstract: Recent studies have speculated a link between Creutzfeldt-Jakob disease (CJD) and COVID-19, following the description of CJD cases after COVID-19 infection. We report the case of a 71-year-old female patient who developed neuropsychiatric and ... ...

    Abstract Recent studies have speculated a link between Creutzfeldt-Jakob disease (CJD) and COVID-19, following the description of CJD cases after COVID-19 infection. We report the case of a 71-year-old female patient who developed neuropsychiatric and neurological symptoms after COVID-19 infection and was later diagnosed with CJD. Cerebrospinal fluid (CSF) total tau levels were slightly increased. She resulted prion protein gene (PRNP) M129V heterozygous. We aim to emphasize the role of the polymorphism at codon 129 of PRNP gene on the clinical phenotype and duration of CJD, and the CSF total tau levels that likely correlate with the rate of disease progression.
    Language English
    Publishing date 2023-02-14
    Publishing country Netherlands
    Document type Journal Article
    ISSN 2542-4823
    ISSN (online) 2542-4823
    DOI 10.3233/ADR-220095
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: The Huntington's Disease Gene in an Italian Cohort of Patients with Bipolar Disorder.

    Ferrari, Camilla / Capacci, Elena / Bagnoli, Silvia / Ingannato, Assunta / Sorbi, Sandro / Nacmias, Benedetta

    Genes

    2023  Volume 14, Issue 9

    Abstract: Background and objectives: Huntington's disease (HD) is characterized by motor, cognitive and psychiatric manifestations and caused by an expansion of CAG repeats over 35 triplets on the huntingtin (: Methods: We assessed the : Results: No patient ...

    Abstract Background and objectives: Huntington's disease (HD) is characterized by motor, cognitive and psychiatric manifestations and caused by an expansion of CAG repeats over 35 triplets on the huntingtin (
    Methods: We assessed the
    Results: No patient was found to be a carrier of the pathological
    Conclusion: The pathological
    MeSH term(s) Humans ; Bipolar Disorder/genetics ; Huntington Disease/genetics ; Alleles ; Genotype ; Family
    Language English
    Publishing date 2023-08-25
    Publishing country Switzerland
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2527218-4
    ISSN 2073-4425 ; 2073-4425
    ISSN (online) 2073-4425
    ISSN 2073-4425
    DOI 10.3390/genes14091681
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Plasma GFAP, NfL and pTau 181 detect preclinical stages of dementia.

    Ingannato, Assunta / Bagnoli, Silvia / Mazzeo, Salvatore / Giacomucci, Giulia / Bessi, Valentina / Ferrari, Camilla / Sorbi, Sandro / Nacmias, Benedetta

    Frontiers in endocrinology

    2024  Volume 15, Page(s) 1375302

    Abstract: Background: Plasma biomarkers are preferable to invasive and expensive diagnostic tools, such as neuroimaging and lumbar puncture that are gold standard in the clinical management of Alzheimer's Disease (AD). Here, we investigated plasma Glial ... ...

    Abstract Background: Plasma biomarkers are preferable to invasive and expensive diagnostic tools, such as neuroimaging and lumbar puncture that are gold standard in the clinical management of Alzheimer's Disease (AD). Here, we investigated plasma Glial Fibrillary Acidic Protein (GFAP), Neurofilament Light Chain (NfL) and Phosphorylated-tau-181 (pTau 181) in AD and in its early stages: Subjective cognitive decline (SCD) and Mild cognitive impairment (MCI).
    Material and methods: This study included 152 patients (42 SCD, 74 MCI and 36 AD). All patients underwent comprehensive clinical and neurological assessment. Blood samples were collected for Apolipoprotein E (APOE) genotyping and plasma biomarker (GFAP, NfL, and pTau 181) measurements. Forty-three patients (7 SCD, 27 MCI, and 9 AD) underwent a follow-up (FU) visit after 2 years, and a second plasma sample was collected. Plasma biomarker levels were detected using the Simoa SR-X technology (Quanterix Corp.). Statistical analysis was performed using SPSS software version 28 (IBM SPSS Statistics). Statistical significance was set at p < 0.05.
    Results: GFAP, NfL and pTau 181 levels in plasma were lower in SCD and MCI than in AD patients. In particular, plasma GFAP levels were statistically significant different between SCD and AD (
    Discussion and conclusions: Plasma GFAP, NfL and pTau 181 are promising biomarkers in the diagnosis of the prodromic stages and prognosis of dementia.
    MeSH term(s) Humans ; Glial Fibrillary Acidic Protein/blood ; Female ; Male ; Neurofilament Proteins/blood ; tau Proteins/blood ; Aged ; Biomarkers/blood ; Cognitive Dysfunction/blood ; Cognitive Dysfunction/diagnosis ; Alzheimer Disease/blood ; Alzheimer Disease/diagnosis ; Middle Aged ; Phosphorylation ; Dementia/blood ; Dementia/diagnosis ; Apolipoproteins E/blood ; Apolipoproteins E/genetics ; Aged, 80 and over ; Follow-Up Studies
    Chemical Substances Glial Fibrillary Acidic Protein ; Neurofilament Proteins ; tau Proteins ; Biomarkers ; neurofilament protein L ; GFAP protein, human ; Apolipoproteins E ; MAPT protein, human
    Language English
    Publishing date 2024-04-09
    Publishing country Switzerland
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2592084-4
    ISSN 1664-2392
    ISSN 1664-2392
    DOI 10.3389/fendo.2024.1375302
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Intermediate alleles of HTT: A new pathway in longevity.

    Ingannato, Assunta / Bagnoli, Silvia / Bessi, Valentina / Ferrari, Camilla / Mazzeo, Salvatore / Sorbi, Sandro / Nacmias, Benedetta

    Journal of the neurological sciences

    2022  Volume 438, Page(s) 120274

    Abstract: Centenarians are the best example of successful aging, reaching extreme longevity escaping age-related diseases. Genome sequencing studies provided evidence for genetic factors linked to heathy long life, including genes related to age-dependent diseases. ...

    Abstract Centenarians are the best example of successful aging, reaching extreme longevity escaping age-related diseases. Genome sequencing studies provided evidence for genetic factors linked to heathy long life, including genes related to age-dependent diseases. HTT (Huntingtin) gene is linked to Huntington's Disease, but also associated to longevity in capuchins and mice. HTT Intermediate alleles (IAs) are defined as CAG repeat expansion between 27 and 35. According to recent data IAs might increase Alzheimer's Disease risk, but also might have a neuroprotective effect and can confer an advantage in brain development. Here, we investigated, for the first time, the possible implication of HTT IAs in extreme longevity and their possible association in cognitive decline. We analysed the distribution of IAs in Italian Centenarians (n = 143) and compared with pathological controls with cognitive decline (n = 232, including 80 Alzheimer's Disease, 78 Frontotemporal Dementia and 74 Subjective Cognitive Decline patients) and healthy controls (n = 104). Our data show a statistically significant higher frequency of IAs in Centenarians with respect to pathological controls with cognitive decline (p = .031; OR = 2.3097 95% CI 1.0591 to 5.0371), with a percentage of 11.2 respect to 5.4 respectively. The highest presence of IAs in Centenarians confirms and extends in humans a possible implication of HTT gene in exceptional lifespan and in brain development with a neuroprotective effect.
    MeSH term(s) Aged, 80 and over ; Alleles ; Alzheimer Disease/genetics ; Animals ; Humans ; Huntingtin Protein/genetics ; Huntington Disease/genetics ; Longevity/genetics ; Mice
    Chemical Substances HTT protein, human ; Huntingtin Protein
    Language English
    Publishing date 2022-05-04
    Publishing country Netherlands
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 80160-4
    ISSN 1878-5883 ; 0022-510X ; 0374-8642
    ISSN (online) 1878-5883
    ISSN 0022-510X ; 0374-8642
    DOI 10.1016/j.jns.2022.120274
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: GRN Missense Variants and Familial Alzheimer's Disease: Two Case Reports.

    Ingannato, Assunta / Bessi, Valentina / Chiari, Annalisa / Salvatori, Davide / Bagnoli, Silvia / Bedin, Roberta / Ferrari, Camilla / Sorbi, Sandro / Nacmias, Benedetta

    Journal of Alzheimer's disease : JAD

    2023  Volume 96, Issue 2, Page(s) 767–775

    Abstract: Background: Progranulin protein (GRN) is a growth factor, encoded by the GRN (Granulin precursor) gene, involved in several functions including inflammation, wound repair, signal transduction, proliferation, and tumorigenesis. Mutations in GRN gene are ... ...

    Abstract Background: Progranulin protein (GRN) is a growth factor, encoded by the GRN (Granulin precursor) gene, involved in several functions including inflammation, wound repair, signal transduction, proliferation, and tumorigenesis. Mutations in GRN gene are usually the genetic etiology of frontotemporal dementia (FTD), but different studies reported GRN mutations in Alzheimer 's disease (AD) patients.
    Objective: Here, we analyzed FTD linked gene GRN in 23 patients with a clinical diagnosis of AD and a family history of AD (FAD), not carrying mutations in AD candidate genes (PSEN 1, PSEN 2, and APP). In addition, Microtubule-associated protein tau (MAPT) gene was studied too. All patients underwent an extensive neuropsychological battery.
    Methods: Genetic analyses were performed thought PCR assay and sequencing. Variants were annotated with ANNOVAR and allele frequency was checked on population databases. In silico prediction tools were consulted to check nonsynonymous variants and their effect on protein function and structure. The clinical data were retrospectively collected from medical records.
    Results: Genetic screening of MAPT and GRN in 23 FAD patients highlighted two rare different variants in two probands (2/23 = 8,7%) located in GRN gene: R433W (p.Arg433Trp) and C521Y (p.Cys521Tyr). The R433W and C521Y are variants with uncertain significant, that are predicted to affect GRN protein structure and function, with a possible damaging effect.
    Conclusions: Our data provide evidence of the importance of GRN genetic analysis also in the study of familial AD.
    MeSH term(s) Humans ; Alzheimer Disease/genetics ; Frontotemporal Dementia/genetics ; Retrospective Studies ; Intercellular Signaling Peptides and Proteins/genetics ; Progranulins/genetics ; Mutation/genetics
    Chemical Substances Intercellular Signaling Peptides and Proteins ; Progranulins ; GRN protein, human
    Language English
    Publishing date 2023-10-29
    Publishing country Netherlands
    Document type Case Reports ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1440127-7
    ISSN 1875-8908 ; 1387-2877
    ISSN (online) 1875-8908
    ISSN 1387-2877
    DOI 10.3233/JAD-230689
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Multilayered Bioorthogonal SERS Nanoprobes Selectively Aggregating in Human Fluids: A Smart Optical Assay for β-Amyloid Peptide Quantification.

    Dallari, Caterina / Lenci, Elena / Trabocchi, Andrea / Bessi, Valentina / Bagnoli, Silvia / Nacmias, Benedetta / Credi, Caterina / Pavone, Francesco Saverio

    ACS sensors

    2023  Volume 8, Issue 10, Page(s) 3693–3700

    Abstract: Alzheimer's disease (AD) is a debilitating neurological condition characterized by cognitive decline, memory loss, and behavioral skill impairment, features that worsen with time. Early diagnosis will likely be the most effective therapy for Alzheimer's ... ...

    Abstract Alzheimer's disease (AD) is a debilitating neurological condition characterized by cognitive decline, memory loss, and behavioral skill impairment, features that worsen with time. Early diagnosis will likely be the most effective therapy for Alzheimer's disease since it can ensure timely pharmacological treatments that can reduce the irreversible progression and delay the symptoms. Amyloid β-peptide 1-42 (Aβ (1-42)) is considered one of the key pathological AD biomarkers that is present in different biological fluids. However, Aβ (1-42) detection still relies on colorimetric and enzyme-linked immunoassays as the gold standard characterized by low accuracy or high costs, respectively. In this context, optical detection techniques based on surface-enhanced Raman spectroscopy (SERS) through advanced nanoconstructs are promising alternatives for the development of novel rapid and low-cost methods for the targeting of Aβ pathological biomarkers in fluids. Here, a multilayered nanoprobe constituted by bioorthogonal Raman reporters (RRs) embedded within two layers of gold nanoparticles (Au@RRs@AuNPs) has been developed and successfully validated for specific detection of Aβ (1-42) in the human cerebrospinal fluid (CSF) with sensitivity down to pg/mL. The smart double-layer configuration enables us to exploit the outer gold NP surfaces for selective absorption of targeted peptide whose concentration controls the aggregation behavior of Au@RRs@AuNPs, proportionally reflected in Raman intensity changes, providing high specificity and sensitivity and representing a significant step ahead of the state of the art on SERS for clinical analyses.
    MeSH term(s) Humans ; Amyloid beta-Peptides/cerebrospinal fluid ; Alzheimer Disease/diagnosis ; Alzheimer Disease/cerebrospinal fluid ; Gold ; Metal Nanoparticles/chemistry ; Biomarkers
    Chemical Substances Amyloid beta-Peptides ; Gold (7440-57-5) ; Biomarkers
    Language English
    Publishing date 2023-09-27
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 2379-3694
    ISSN (online) 2379-3694
    DOI 10.1021/acssensors.3c00225
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Understanding the interplay between APO E polymorphism and cognition in the Italian oldest old: results from the "Mugello study".

    Lombardi, Gemma / Pancani, Silvia / Bagnoli, Silvia / Vannetti, Federica / Nacmias, Benedetta / Sorbi, Sandro / Cecchi, Francesca / Macchi, Claudio

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

    2023  Volume 45, Issue 2, Page(s) 539–546

    Abstract: Introduction: Recent data suggest that the deleterious effect on general health and cognition of ε4 allele of Apolipoprotein E (ApoE) observed in the elderly population, may attenuate in extreme aging. This study aimed to describe the ApoE genotype ... ...

    Abstract Introduction: Recent data suggest that the deleterious effect on general health and cognition of ε4 allele of Apolipoprotein E (ApoE) observed in the elderly population, may attenuate in extreme aging. This study aimed to describe the ApoE genotype distribution and its relationship with cognition in a group of nonagenarians living in the Mugello area, Italy.
    Material and methods: Cognition was evaluated using the Mini-Mental-State-Examination (MMSE). DNA was extracted from blood samples to determine ApoE genotyping. Participants were classified into three ApoE groups (ε2, ε3, ε4). Logistic and linear regression models were created, to assess the relationship between ApoE genotype group and dementia diagnosis and cognitive performance, respectively.
    Results: 169 subjects were included. ApoE ε3 was the most prevalent genotype (76.3%). Dementia prevalence was 26.6% and it was not associated with the presence of ApoE ε4. Participants of ε4 group were significantly more likely to have lower cognitive performances than ε2 and ε3, independently of a dementia diagnosis.
    Discussion: Results support that ApoE genotype no longer plays a role in the health condition of the oldest old, however, an interaction is detectable between ApoE polymorphism and cognitive performances at this extreme age.
    MeSH term(s) Aged ; Aged, 80 and over ; Humans ; Apolipoprotein E4/genetics ; Apolipoproteins E/genetics ; Cognition ; Dementia ; Genotype ; Polymorphism, Genetic/genetics
    Chemical Substances Apolipoprotein E4 ; Apolipoproteins E ; ApoE protein, human
    Language English
    Publishing date 2023-09-15
    Publishing country Italy
    Document type Journal Article
    ZDB-ID 2016546-8
    ISSN 1590-3478 ; 1590-1874
    ISSN (online) 1590-3478
    ISSN 1590-1874
    DOI 10.1007/s10072-023-07073-4
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top